XTX Topco Ltd raised its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 312.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,033 shares of the company’s stock after purchasing an additional 14,420 shares during the period. XTX Topco Ltd’s holdings in Ryan Specialty were worth $1,221,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Rakuten Securities Inc. acquired a new position in shares of Ryan Specialty during the 4th quarter worth $27,000. Principal Securities Inc. grew its position in Ryan Specialty by 164.7% in the fourth quarter. Principal Securities Inc. now owns 667 shares of the company’s stock valued at $43,000 after acquiring an additional 415 shares during the last quarter. Mizuho Bank Ltd. acquired a new position in Ryan Specialty during the fourth quarter worth about $49,000. Headlands Technologies LLC lifted its holdings in shares of Ryan Specialty by 2,644.8% in the fourth quarter. Headlands Technologies LLC now owns 796 shares of the company’s stock worth $51,000 after acquiring an additional 767 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd acquired a new stake in shares of Ryan Specialty in the 4th quarter valued at approximately $54,000. 84.82% of the stock is currently owned by institutional investors.
Insider Transactions at Ryan Specialty
In related news, EVP Brendan Martin Mulshine sold 30,000 shares of the company’s stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Nicholas Dominic Cortezi sold 10,485 shares of Ryan Specialty stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $65.12, for a total value of $682,783.20. Following the transaction, the director now owns 11,109 shares of the company’s stock, valued at $723,418.08. This trade represents a 48.56 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 211,894 shares of company stock valued at $14,089,370 over the last ninety days. 11.10% of the stock is owned by company insiders.
Ryan Specialty Stock Performance
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The company had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. As a group, sell-side analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.
Ryan Specialty Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.65%. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Tuesday, March 4th. Ryan Specialty’s dividend payout ratio is presently 69.57%.
Wall Street Analysts Forecast Growth
RYAN has been the subject of a number of research reports. Barclays cut their price objective on Ryan Specialty from $88.00 to $83.00 and set an “overweight” rating on the stock in a report on Friday. Royal Bank of Canada reduced their price target on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a report on Friday, February 21st. UBS Group upped their price objective on Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. TD Cowen initiated coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They set a “buy” rating and a $89.00 target price on the stock. Finally, Wells Fargo & Company decreased their price target on shares of Ryan Specialty from $69.00 to $66.00 and set an “equal weight” rating for the company in a research report on Thursday, April 10th. One analyst has rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $75.67.
Read Our Latest Stock Analysis on RYAN
Ryan Specialty Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Stories
- Five stocks we like better than Ryan Specialty
- How to Short a Stock in 5 Easy StepsĀ
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- A Deeper Look at Bid-Ask Spreads
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- Options Trading – Understanding Strike Price
- 3 Hot New IPOs Defying the 2025 Market Slump
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.